Skip to content

The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00905723
Enrollment
60
Registered
2009-05-20
Start date
2009-05-31
Completion date
Unknown
Last updated
2009-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Symptoms

Keywords

climacterium, sexual life, isoflavone, estrogen, McCoy's sexual questionnaire, Kupperman index

Brief summary

Climacterium is marked by hypoestrogenism and it is associated to drastic vasomotors symptoms, genital atrophy and humor alteration. Additionally, these symptoms impair sexual life and life quality. These effects can be counteracted by administration of estrogen therapy. However, estrogen therapy has side effects and isoflavone has been proposed as an estrogen substitute in reposition therapy. The aim of the randomized controlled trial is to evaluate the effects of isoflavone in the sex life assessed by a modified McCoy's sexual questionnaire.

Interventions

DRUGestradiol

1 mg daily for 6 months

150 mg isoflavone daily for 6 months

DRUGPlacebo

sugar pill daily for six months

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* women aged 45-65 years old * presenting climacteric symptoms * sexual complaints

Exclusion criteria

* hormonal therapy * counter indication to hormonal therapy * uncontrolled comorbidities

Design outcomes

Primary

MeasureTime frame
McCoy's sexual questionnaireat recruitment and six months later

Secondary

MeasureTime frame
Kupperman's indexat recruitment and six months later

Countries

Brazil

Contacts

Primary ContactTeresa R Embiruçu, M.D.
embirucu2@yahoo.com.br5511-75413521
Backup ContactRegiane HB Rabelo, M.D.
gianehelena@ig.com.br5511-72307128

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026